CATALOGO DEI PRODOTTI DELLA RICERCA

BELLINATO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.041
EU - Europa 882
AS - Asia 362
OC - Oceania 43
SA - Sud America 25
AF - Africa 12
Totale 2.365
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.016
IT - Italia 194
CN - Cina 174
IE - Irlanda 157
SE - Svezia 132
FR - Francia 98
GB - Regno Unito 76
SG - Singapore 76
DE - Germania 68
AU - Australia 39
FI - Finlandia 29
ES - Italia 24
TR - Turchia 24
RU - Federazione Russa 22
BR - Brasile 13
JP - Giappone 13
MX - Messico 12
CA - Canada 11
HK - Hong Kong 11
IN - India 11
MY - Malesia 11
IR - Iran 10
NL - Olanda 10
UA - Ucraina 10
CL - Cile 9
PL - Polonia 9
DK - Danimarca 8
HR - Croazia 6
KR - Corea 6
PH - Filippine 6
SA - Arabia Saudita 6
BE - Belgio 5
IS - Islanda 5
RO - Romania 5
AT - Austria 4
CH - Svizzera 4
DZ - Algeria 4
NZ - Nuova Zelanda 4
EG - Egitto 3
IL - Israele 3
NO - Norvegia 3
PT - Portogallo 3
CO - Colombia 2
CZ - Repubblica Ceca 2
ID - Indonesia 2
JO - Giordania 2
MA - Marocco 2
PK - Pakistan 2
TW - Taiwan 2
AD - Andorra 1
AL - Albania 1
BG - Bulgaria 1
FK - Isole Falkland (Malvinas) 1
GT - Guatemala 1
KE - Kenya 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
NG - Nigeria 1
PR - Porto Rico 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 2.365
Salva come PNG Salva come JPEG
Città #
Chandler 267
Dublin 146
Ashburn 137
Beijing 58
New York 40
Singapore 40
Southend 39
Lawrence 34
Princeton 34
Sindelfingen 25
Wilmington 25
Houston 24
Jacksonville 24
Seattle 24
Washington 24
Helsinki 23
Verona 22
Milan 21
Sydney 16
Venice 14
Enfield 12
Kuala Lumpur 11
Los Angeles 10
Bologna 9
Chicago 9
Dongguan 9
Esslingen am Neckar 9
Frankfurt am Main 9
Perth 9
London 8
Madrid 8
Mersin 8
Tokyo 8
Amsterdam 7
Copenhagen 7
Hong Kong 7
Phoenix 7
San Jose 7
Ann Arbor 6
Atlanta 6
Jinan 6
Kent 6
Lappeenranta 6
Mexico City 6
Redwood City 6
Riyadh 6
Rome 6
Santiago 6
Seoul 6
Warsaw 6
Chennai 5
Hebei 5
Nanjing 5
Redmond 5
Adelaide 4
Albano Laziale 4
Brisbane 4
Brussels 4
Bucharest 4
Constantine 4
Fuzhou 4
Genoa 4
Giresun 4
Las Vegas 4
Nova Iguaçu 4
Palermo 4
Vicenza 4
Woodbridge 4
Zagreb 4
Zhengzhou 4
Zurich 4
Barcelona 3
Bari 3
Berlin 3
Campbelltown 3
Council Bluffs 3
Fairfield 3
Faskrudsfjoerdur 3
Florence 3
Guangzhou 3
Hangzhou 3
Lund 3
Meridian 3
Miami 3
Mumbai 3
Olinda 3
Pasig 3
Quezon City 3
Rotterdam 3
Shanghai 3
Tehran 3
The Dalles 3
Tianjin 3
Toronto 3
Trieste 3
Wroclaw 3
Aalen 2
Amman 2
Antalya 2
Baoding 2
Totale 1.434
Salva come PNG Salva come JPEG
Nome #
Dietary supplements for lipedema 191
Polymorphisms, diet and nutrigenomics 94
Il ruolo della vitamina D nella dermatite atopica 80
BRAF V600E expression in juvenile xanthogranuloma occurring after Langerhans cell histiocytosis. 62
Amicrobial Pustulosis of the Folds: Report of Three New Cases 58
Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid 54
A systematic review of treatments for pityriasis lichenoides 53
A dermatologist perspective in the pharmacological treatment of patients with psoriasis and psoriatic arthritis 51
Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review 50
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end-products 50
Persistent localized hypertrichosis in a Caucasian child at sites of DTPa and chickenpox vaccination 47
Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature 46
Consensus on the place in therapy of TNF-a inhibitors in the treatment of patients with chronic plaque psoriasis 45
Coexistence of scleromyxedema and Sneddon syndrome 45
Hypochondriasis and Personality Traits of Patients with Chronic Plaque Psoriasis 44
Adrenergic urticaria successfully treated with omalizumab 43
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis 43
Dietary supplements for the management of COVID-19 symptoms 42
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 42
Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities 40
Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines 40
Psychological Stress and Salivary Cortisol Levels in Patients with Plaque Psoriasis 40
Impact of the COVID-19 pandemic on melanoma diagnosis 39
Clinical profile and co-infections of urethritis in males 38
Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease 37
Relapse of psoriasis in patients who asked to discontinue etanercept after achieving a stable clinical remission. 35
Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis 34
Clinical‐epidemiological aspects of the Monkeypox 2022 epidemic: a multicenter study by the Italian SIDeMaST Group of Sexually Transmitted, Infectious and Tropical Diseases 34
IL-17A inhibitors in patients with chronic plaque psoriasis and history of malignancy: A case series with systematic literature review 34
Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review 33
Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study 30
The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events 30
Methotrexate vs secukinumab safety in psoriasis patients with metabolic syndrome 30
Skin adverse reactions to Sars‐CoV‐2 vaccination: a relevant responsibility issue for dermatologists 30
Dermoscopic features of nevoid melanoma: a retrospective study 29
Comparative dermoscopy assessment of nevus-associated versus de novo in situ melanoma 29
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis 28
Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies 28
Primary nodular localized cutaneous amyloidosis of the scalp associated with systemic lupus erythematosus 28
Latest Advances for the Treatment of Chronic Plaque Psoriasis with Biologics and Oral Small Molecules 27
Spesolimab in patients with flare of generalized pustular psoriasis: A multicentre case-series 26
The Risk of COVID‐19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments 26
Predictors of subsequent primary melanoma: a case-control study 25
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study 25
The transition from mild to moderate-to-severe chronic plaque psoriasis 25
Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic Therapies 25
Risk of lymphohematologic malignancies in patients with chronic plaque psoriasis: A systematic review with meta-analysis 25
Monkeypox virus infection: what dermatologist needs to know? 24
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis 23
Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab 21
The impact of biologic therapy for moderate-to-severe psoriasis on the immune responses to SARS-CoV2 infection and vaccination 21
In vitro cell culture of amniotic fluid keratinocytes on amniotic membrane: the ideal tissue for repairing skin ulcers 21
Dupilumab for recalcitrant Kimura disease 21
Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis 20
Could Targeted Pharmacotherapies Exert a "Disease Modification Effect" in Patients with Chronic Plaque Psoriasis? 20
Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis 19
Scurvy as Presenting Sign of Anorexia Nervosa 18
Main nutritional deficiencies 17
Is risankizumab as needed administration a good option for patients with plaque psoriasis? 17
Central Pain Sensitization in Patients with Chronic Plaque Psoriasis 16
Cutaneous Adverse Reactions to SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis 16
Reduction of cutaneous advanced glycation end products levels after effective psoriasis treatment 16
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis 15
Topographic Differential Diagnosis of Chronic Plaque Psoriasis: Challenges and Tricks 15
Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs 13
Validating methods for testing natural molecules on molecular pathways of interest in silico and in vitro 12
Optimization of long-range PCR protocol to prepare filaggrin exon 3 libraries for PacBio long-read sequencing 11
Polyphenols and Lactobacillus reuteri in oral health 10
Price variability of TNF-α inhibitor biosimilars among European countries 10
Corymbose Syphilis 10
Managing the Patient with Psoriasis and Metabolic Comorbidities 7
Systematic study on nail plate assessment: differences in nail plate shape, thickness, power Doppler signal and scanning approach 6
The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments 6
Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis 6
Generalized pustular psoriasis successfully treated with spesolimab: A case report 4
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort 4
Long-term follow-up of Zoon balanitis: a retrospective cohort study 4
Psoriasis: talking points from recent clinical trials 4
Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis 3
Awareness of obesity among patients with psoriasis 3
Omics sciences and precision medicine in melanoma 3
X-linked genodermatoses from diagnosis to tailored therapy 3
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study 2
Lamivudine, Doravirine, and Cabotegravir downregulate the expression of Human Endogenous Retroviruses (HERVs), inhibit cell growth, and reduce invasive capability in melanoma cell lines 2
PsoBioVax: A multicentric Italian case–control study of the immunological response to anti‐SARS‐CoV‐2 vaccine among psoriatic patients under biological therapy 2
Totale 2.455
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.750
article - articoli 13.750
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.500
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202039 1 1 0 0 7 5 0 1 3 12 3 6
2020/202195 9 6 1 14 15 14 10 1 4 4 13 4
2021/2022224 12 27 4 12 31 12 15 16 11 12 17 55
2022/20231.126 38 72 63 144 63 203 15 53 210 157 78 30
2023/2024940 59 64 97 102 82 166 67 57 16 44 108 78
2024/202529 29 0 0 0 0 0 0 0 0 0 0 0
Totale 2.455